Intervacc is trading 13.2% down at €0.08 after another session of thin, range-bound trading and elevated volatility.
- The move appears driven by routine swings in a highly volatile small-cap biotech rather than a clear new catalyst.
- There are no fresh company announcements, earnings, regulatory decisions, or major analyst actions linked to the price decline.